Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Alzheimers Disease
Interventions
RADIATION

[123-I] AV-83 Injection and Imaging Procedures

Evaluation of \[123I\] AV83 and SPECT as a marker of beta-amyloid protein deposition in subjects with Alzheimer disease in comparison to healthy subjects

Trial Locations (1)

06510

Molecular NeuroImaging, New Haven

Sponsors
All Listed Sponsors
collaborator

Institute for Neurodegenerative Disorders

OTHER

lead

Molecular NeuroImaging

OTHER